4,4',4''-(Benzene-1,3,5-triyltris(oxy))trianiline

Catalog No.: 
ACOSTG037
CAS No.: 
102852-92-6
Molecular Formula: 
C24H21N3O3
Molecular Weight: 
399.45
4,4',4''-(Benzene-1,3,5-triyltris(oxy))trianiline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$101.00In stockIn stock
25g95%$446.00In stockIn stock
100g95%$1516.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4',4''-(Benzene-1,3,5-triyltris(oxy))trianiline
IUPAC Name4,4',4''-(benzene-1,3,5-triyltris(oxy))trianiline
MDL No.MFCD09908237
Molecular FormulaC24H21N3O3
Molecular Weight399.45
SMILESNC1=CC=C(OC2=CC(OC3=CC=C(C=C3)N)=CC(OC4=CC=C(C=C4)N)=C2)C=C1
InChI KeyPAPDRIKTCIYHFI-UHFFFAOYSA-N
SynonymSB83725 | CS0010 | CEA85292 | FT-0775097 | Benzenamine, 4,4',4''-[1,3,5-benzenetriyltris(oxy)]tris- | AKOS005266414 | 1,3,5-TRIS(4-AMINOPHENOXY)BENZENE (135TAPOB) | AS-66460 | 4,4',4''-(Benzene-1,3,5-triyltris(oxy))trianiline | J-000822 | 4-[3,5-bis(4-ami
CAS No.102852-92-6
PubChem CID21185049

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACOSTG037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOSTG037 route product structure diagram
    ACOSTG037102852-92-6In Stock
Inquiry

2. ACOSTG037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOSTG037 route product structure diagram
    ACOSTG037102852-92-6In Stock
Inquiry

3. ACOSTG037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOSTG037 route product structure diagram
    ACOSTG037102852-92-6In Stock
Inquiry

Comments (0)